Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A Phase 3 Trial of Thymoglobuline for Prevention of Chronic Gvhd in Transplantation from an HLA-Matched Sibling

Gi June Min, MD, Byung Sik Cho, MD, PhD, Sung-Soo Park, MD, PhD, Silvia Park, MD PhD, Seung-Ah Yahng, MD, PhD, Young-Woo Jeon, MD PhD, Seung-Hwan Shin, MD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD PhD, Ki-Seong Eom, MD, PhD, Yoo-Jin Kim, MD, PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD, PhD, Dong-Wook Kim, MD, Jong Wook Lee, MD, PhD, Heeje Kim, MD PhD, Seok Lee, MD, PhD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-139234

Published: 2020

Journal Articles

Comparison of Myeloablative (CyTBI, BuCy) Versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Low WT1 Expression Level at Transplant

Silvia Park, GI June MIN, MD, Sung-Soo Park, Seung-Ah Yahng, MD PhD, Young-Woo Jeon, MD PhD, Seung-Hwan Shin, MD PhD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD, Byung-Sik Cho, MD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Chang Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, Jong-Wook Lee, MD PhD, Hee-Je Kim, MD PhD

Blood (2019) 134 (Supplement_1): 1973.

https://doi.org/10.1182/blood-2019-128306

Published: 2019

Journal Articles

Physical and Psychological Impairments As Practical Frailty Markers in Elderly AML Fit for Intensive Chemotherapy; Interim Data of a Prospective Cohort Study

GI June MIN, MD, Byung Sik Cho, MD PhD, Sung-Soo Park, MD, Silvia Park, Young-Woo Jeon, MD PhD, Seung-Hwan Shin, MD PhD, Seung-Ah Yahng, MD PhD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Seok-Goo Cho, MD PhD, Chang-Ki Min, MD PhD, Dong-Wook Kim, Jong-Wook Lee, MD PhD, Hee-Je Kim, MD PhD

Blood (2019) 134 (Supplement_1): 3831.

https://doi.org/10.1182/blood-2019-123584

Published: 2019

Journal Articles

Validation of Recently Proposed Risk and Prognostic Factors for Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Gi June Min, MD, Hee-Je Kim, MD PhD, Sung-Soo Park, MD, Silvia Park, Young-Woo Jeon, MD PhD, Seung-Ah Yahng, MD PhD, Seung-Hwan Shin, MD PhD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD, Byung Sik Cho, MD PhD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, Jong-Wook Lee, MD PhD

Blood (2019) 134 (Supplement_1): 3260.

https://doi.org/10.1182/blood-2019-124275

Published: 2019

Journal Articles

Measurable Residual Disease Assay with WT1 Expression in Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation; Optimal Threshold, Time Points, and Candidates

Byung Sik Cho, MD PhD, GI June MIN, MD, Heeje Kim, MD PhD, Seug Yun Yoon, MD, Sung-Soo Park, MD, Silvia Park, MD PhD, Seung-Ah Yahng, MD PhD, Young-Woo Jeon, MD PhD, Seung-Hwan Shin, MD PhD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD PhD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD PhD

Blood (2018) 132 (Supplement 1): 2759.

https://doi.org/10.1182/blood-2018-99-110042

Published: 2018

Journal Articles

Specific Donor Human Leukocyte Antigen (HLA) Allotypes and CMV IgG Serology Status Predict the Risk of Cytomegalovirus-Related Disease in Acute Myeloid Leukemia Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2018) 132 (Supplement 1): 2076.

https://doi.org/10.1182/blood-2018-99-113233

Published: 2018

Journal Articles

Improved Outcomes of Low-Dose Cytarabine Regimen By Increased Dose and Duration of Cytarabine in Combination with Oral Etoposide for Elderly Acute Myeloid Leukemia

Seung-Hwan Shin, MD, Seung-Ah Yahng, MD, Jae-Ho Yoon, MD, Byung-Sik Cho, MD, Hee-Je Kim, MD, Young-Woo Jeon, MD, Sung-Eun Lee, MD, Ki-Sung Eom, MD, Yoo-Jin Kim, MD, Seok Lee, MD, Chang-Ki Min, MD, Seok-Goo Cho, MD, Dong-Wook Kim, Jong-Wook Lee, MD, Woo-Sung Min, MD

Blood (2015) 126 (23): 1338.

https://doi.org/10.1182/blood.V126.23.1338.1338

Published: 2015

Journal Articles

The Characteristics of Hemorrhagic Cystitis After Allogeneic Stem Cell Transplantation, and Possible Predictive Value of Absolute Lymphocyte Count for Clinical Outcome.

Seung-Ah Yahng, MD, Byung-Sik Cho, MD, Sung-Eun Lee, MD, Ki-Seong Eom, MD, Yoo-Jin Kim, MD, Hee-Je Kim, MD, Seok Lee, MD, Chang-Ki Min, MD, Seok-Goo Cho, MD, Dong-Wook Kim, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Chong-Won Park, MD

Blood (2010) 116 (21): 1284.

https://doi.org/10.1182/blood.V116.21.1284.1284

Published: 2010

Journal Articles

Full Haplotype Mismatch Stem Cell Transplantation: Myeloablative with T-Cell Depletion Vs. Reduced Intensity Conditioning without T-Cell Depletion

Heeje Kim, MD, PhD, Woo-Sung Min, MD, PhD, Ki-Seong Eom, MD, PhD, Byung-Sik Cho, MD, Seung-Ah Yahng, MD, Sung-Eun Lee, MD, Yoo-Jin Kim, MD, Seok Lee, MD, PhD, Chang-Ki Min, MD, PhD, Seok-Goo Cho, MD, PhD, Jong-Wook Lee, MD, PhD, Chong-Won Park, MD, PhD

Blood (2010) 116 (21): 3533.

https://doi.org/10.1182/blood.V116.21.3533.3533

Published: 2010

Journal Articles

The Potential Role of Circulating IL-17 Levels During the Peri-Transplant Period as a Predictor for Early Leukemia Relapse After Allogeneic Stem Cell Transplantation.

Byung Sik Cho, Ji-Young Lim, Seung-Ah Yahng, MD, Sung-Eun Lee, Ki-Seong Eom, MD, Yoo-Jin Kim, Nak-Gyun Chung, MD, PhD, Dae-Chul Jeong, MD, PhD, Seok Lee, M.D., Heeje Kim, Seok-Goo Cho, MD, PhD, Dong-Wook Kim, MD, PhD, Jong-Wook Lee, MD, PhD, Woo-Sung Min, Chong-Won Park, MD, Chang-Ki Min

Blood (2010) 116 (21): 3454.

https://doi.org/10.1182/blood.V116.21.3454.3454

Published: 2010

Journal Articles

Prognostic Impact of Pretransplant Transfusion Amount on Outcome After Allogeneic Stem Cell Transplantation In Adult Patients with Severe Aplastic Anemia

Sung-Eun Lee, MD, Jong-Wook Lee, MD, Seung-Ah Yahng, MD, Byung-Sik Cho, MD, Ki-Seong Eom, MD, Yoo-Jin Kim, MD, Heeje Kim, MD, Chang-Ki Min, MD, Seok Lee, MD, Seok-Goo Cho, MD, Dong-Wook Kim, MD, Woo-Sung Min, MD, Chong-Won Park, MD

Blood (2010) 116 (21): 3503.

https://doi.org/10.1182/blood.V116.21.3503.3503

Published: 2010

Journal Articles

Long-Term Outcomes of TBI-Based Myeloablative SCT In 292 Consecutive Adults with Ph-Negative ALL: Similar Outcomes for Transplantation Using Related Donor, Well-Matched Unrelated Donor, or Partially Matched Unrelated Donor Sources

Seok Lee, M.D., Seung-Ah Yahng, MD, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, M.D., Yoo-Jin Kim, Hee-Je Kim, MD, Chang-Ki Min, Seok-Goo Cho, MD, PhD, Dong-Wook Kim, Jong-Wook Lee, MD, PhD, Woo-Sung Min, Chong-Won Park, MD

Blood (2010) 116 (21): 2355.

https://doi.org/10.1182/blood.V116.21.2355.2355

Published: 2010

NARROW

A Phase 3 Trial of Thymoglobuline for Prevention of Chronic Gvhd in Transplantation from an HLA-Matched Sibling

Comparison of Myeloablative (CyTBI, BuCy) Versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Low WT1 Expression Level at Transplant

Physical and Psychological Impairments As Practical Frailty Markers in Elderly AML Fit for Intensive Chemotherapy; Interim Data of a Prospective Cohort Study

Validation of Recently Proposed Risk and Prognostic Factors for Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Measurable Residual Disease Assay with WT1 Expression in Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation; Optimal Threshold, Time Points, and Candidates

Specific Donor Human Leukocyte Antigen (HLA) Allotypes and CMV IgG Serology Status Predict the Risk of Cytomegalovirus-Related Disease in Acute Myeloid Leukemia Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation

Improved Outcomes of Low-Dose Cytarabine Regimen By Increased Dose and Duration of Cytarabine in Combination with Oral Etoposide for Elderly Acute Myeloid Leukemia

The Characteristics of Hemorrhagic Cystitis After Allogeneic Stem Cell Transplantation, and Possible Predictive Value of Absolute Lymphocyte Count for Clinical Outcome.

Full Haplotype Mismatch Stem Cell Transplantation: Myeloablative with T-Cell Depletion Vs. Reduced Intensity Conditioning without T-Cell Depletion

The Potential Role of Circulating IL-17 Levels During the Peri-Transplant Period as a Predictor for Early Leukemia Relapse After Allogeneic Stem Cell Transplantation.

Prognostic Impact of Pretransplant Transfusion Amount on Outcome After Allogeneic Stem Cell Transplantation In Adult Patients with Severe Aplastic Anemia

Long-Term Outcomes of TBI-Based Myeloablative SCT In 292 Consecutive Adults with Ph-Negative ALL: Similar Outcomes for Transplantation Using Related Donor, Well-Matched Unrelated Donor, or Partially Matched Unrelated Donor Sources

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only